옵션 체인은 다양한 행사가격과 만기일에 대한 Maxeon Solar Technologies의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Maxeon Solar Technologies에 대한 시장 심리를 평가합니다..

Maxeon Solar Technologies (NASDAQ:MAXN) 주식, 옵션 체인

Maxeon Solar Technologies

Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, France, Italy, and others.

Analyst Color

Government

Large Cap

News

Downgrades

Price Target

Analyst Ratings

Movers

Trading Ideas

General

FSLR

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

SEDG

TPIC

최근 미국 대통령 선거 결과, 특히 공화당의 압승은 도널드 트럼프 대통령 당선인의 지도하에 재생 에너지의 미래에 대한 의문을 제기했다. 모건 스탠리의 보고서는 다양한 정책 시나리오에 따른 재생 에너지의 경제적 영향을 평가하고, 이것이 수익성에 미치는 영향을 분석한다.

트럼프의 당선, 경제적 도전으로 인해 재생 에너지 주식의 전망이 암울: 모건 스탠리

Maxeon Solar Technologies Ltd

UBS analyst Brennan Hawken upgrades Janus Henderson Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JHG#NYSE">JHG</a>) from Neutral to Buy and raises the price target from $45 to $50.

Upgrades

Janus Henderson Group plc Ordinary Shares

UBS Upgrades Janus Henderson Group to Buy, Raises Price Target to $50

HAE Attack Rates in Pediatric Patients 2 to &lt;12 Years of Age with Prophylactic Berotralstat: Results from Interim Analysis of APeX-P
<ul>
<li>ORLADEYO was safe and well tolerated in APeX-P, with no new safety signals identified. Adverse events (AEs) were similar across all ages and weights.</li>
<li>ORLADEYO resulted in early and sustained reductions in monthly attack rates. The median (range) and mean (±SEM) monthly attack rates in the standard-of-care period were 0.96 (0–5.0) and 1.5 (±0.2) attacks/month, respectively. After one month of taking ORLADEYO, median and mean monthly attack rates dropped to 0 (0-4.0) and 0.5 (±0.2), and the median monthly attack rate remained at 0 through month 12 (month 12 range: 0-1.7); the mean monthly attack rate at month 12 was 0.3 (±0.1).</li>
<li>Eighty-three percent of participants experienced symptom onset before six years of age and 90 percent were diagnosed with HAE in the same timeframe.</li>
</ul>

Biotech

Health Care

BCRX

BioCryst Pharmaceuticals Announced Results From An Interim Analysis Of The Ongoing Apex-p Clinical Trial Evaluating An Oral Granule Formulation Of Once-daily Orladeyo (Berotralstat) In Pediatric Patients With Hereditary Angioedema Aged 2 To <12 Years

The companies will evaluate ivonescimab, a novel, investigational PD-1 / VEGF bispecific antibody, in combination with several of Pfizer's antibody drug conjugates (ADCs) across multiple solid tumor settings.
Under the terms of the agreement, Summit will provide ivonescimab for use in the proposed studies, and Pfizer will be responsible for conducting the operations of the studies. The studies will be overseen by both Summit and Pfizer. Both parties retain their respective rights to their products. The studies combining ivonescimab with Pfizer's vedotin ADCs are planned to begin in the middle of this year. Further details on the clinical trials will be announced at a later date.

SMMT

Summit Therapeutics Enters Clinical Trial Collaboration With Pfizer, No Financial Terms Disclosed

Belcan, LLC (a Cognizant company), a global supplier of design, software, manufacturing, supply chain, information technology, and digital engineering solutions to the aerospace, defense, space, automotive, industrial, marine, and government services markets, today announced the opening of its new office in Toulouse, France. This strategic expansion enables the company to better support the growing demands of the global aerospace and defense industry, as well as local original equipment manufacturers (OEMs).
&nbsp;
Located in the heart of Toulouse's aerospace valley, the new office will allow key industry players, including major OEMs, tier-one suppliers, and other industry partners, to easily access Belcan's expertise in design, analysis, and digitalization.

CTSH

Cognizant Owned Belcan Expands Global Footprint With New Aerospace and Defense Office in Toulouse

Owens-Corning (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OC#NYSE">OC</a>) reported quarterly earnings of $3.22 per share which beat the analyst consensus estimate of $2.90 by 11.03 percent. This is a 0.31 percent increase over earnings of $3.21 per share from the same period last year. The company reported quarterly sales of $2.84 billion which beat the analyst consensus estimate of $2.77 billion by 2.46 percent. This is a 23.26 percent increase over sales of $2.30 billion the same period last year.

Earnings

Earnings Beats

Owens-Corning Q4 2024 Adj EPS $3.22 Beats $2.90 Estimate, Sales $2.84B Beat $2.77B Estimate

UBS analyst Paul Gong upgrades XPeng (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) from Sell to Neutral and raises the price target from $8.8 to $18.

XPEV

UBS Upgrades XPeng to Neutral, Raises Price Target to $18

COST MOVES UP OVER 8 POINTS AFTER ALERT
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="902" height="638" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/02/21215256/Screen-Shot-2025-02-21-at-4.53.52-PM.png" alt="" class="wp-image-6296" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/02/21215256/Screen-Shot-2025-02-21-at-4.53.52-PM.png 902w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/02/21215256/Screen-Shot-2025-02-21-at-4.53.52-PM-300x212.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/02/21215256/Screen-Shot-2025-02-21-at-4.53.52-PM-768x543.png 768w" sizes="(max-width: 902px) 100vw, 902px" /></figure>
Costco Inc. (COST) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions. 
Today, at 10:16 AM on February 21st, a significant trading signal occurred for Costco, Inc. (COST) as it demonstrated a Power Inflow at a price of $1027.75. This indicator is crucial for traders who want to know directionally where institutions and so-called "smart money" moves in the market. They see the value of utilizing order flow analytics to guide their trading decisions. The Power Inflow points to a possible uptrend in Costco&#8217;s stock, marking a potential entry point for traders looking to capitalize on the expected upward movement. Traders with this signal closely watch for sustained momentum in Costco&#8217;s stock price, interpreting this event as a bullish sign.
Signal description
Order flow analytics, aka transaction or market flow analysis, separate and study both the retail and institutional volume rate of orders (flow). It involves analyzing the flow of buy and sell orders, along with size, timing, and other associated characteristics and patterns, to gain insights and make more informed trading decisions. This particular indicator is interpreted as a bullish signal by active traders.&nbsp;
The Power Inflow occurs within the first two hours of the market open and generally signals the trend that helps gauge the stock&#8217;s overall direction, powered by institutional activity in the stock, for the remainder of the day.&nbsp;
By incorporating order flow analytics into their trading strategies, market participants can better interpret market conditions, identify trading opportunities, and potentially improve their trading performance. But let's not forget that while watching smart money flow can provide valuable insights, it is crucial to incorporate effective risk management strategies to protect capital and mitigate potential losses. Employing a consistent and effective risk management plan helps traders navigate the uncertainties of the market in a more controlled and calculated manner, increasing the likelihood of long-term success
If you want to stay updated on the latest options trades for COST, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts. 
<a href="https://benzinga.com/apis?_gl=1&#x2A;1hlgn5i&#x2A;_ga&#x2A;MTY1NjE2NTYxMi4xNzE0NzQ4MTAy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDc0ODEwMi4xLjEuMTcxNDc0ODQyOC4wLjAuMA..">Market News and Data brought to you by Benzinga APIs</a> and include firms, like&nbsp; &nbsp; <a href="https://www.tradepulse.net">https://www.tradepulse.net</a>&nbsp; which are responsible for parts of the data within this article. 
&#xA9; 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
After Market Close UPDATE:
The price at the time of the Power Inflow was $1027.75. The returns on the High price ($1036.21) and Close price ($1035.03) after the Power Inflow were respectively 1.0% and 0.5%. That is why it is important to have a trading plan that includes Profit Targets and Stop Losses that reflect your risk appetite. In this case the high of the day and close were very close but that is not always the case
Past Performance is Not Indicative of Future Results

Equities

Technicals

Signals

COST

Costco Stock Rises 1% After This Signal, Despite Market Sell-off

UBS analyst Gavin Parsons upgrades RTX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) from Neutral to Buy and raises the price target from $142 to $147.

UBS Upgrades RTX to Buy, Raises Price Target to $147

EV startup Lucid Motors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>) awarded a<a href="https://www.benzinga.com/news/23/08/33653286/lucid-air-sapphire-specs-revealed-quicker-than-a-tesla-model-s-plaid"> custom Lucid Air Saphhire</a> to the winner of the Saudi Cup over the weekend, complete with a lavender exterior. 
What Happened: Lucid is a Califoria-based EV startup and the Saphhire is the most premium variant of its flagship Lucid Air sedan. The vehicle, priced at about $250,000, usually comes in a sapphire blue metallic paint.
However, at the Saudi Cup event on Saudi Founding Day, Lucid awarded a custom Air Sapphire to the winner, complete with lavender exteriors and interiors.
&#8220;No other car like it exists—nor will it ever,&#8221; Lucid Motors said in a social media post. The Saudi Cup edition of the vehicle also has an Italian-crafted interior aimed at making the vehicle resemble lavender flowers that bloom in the Middle Eastern country in certain seasons.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://t.co/aBoWEiEJRq">pic.twitter.com/aBoWEiEJRq</a>
&mdash; Lucid Motors (@LucidMotors) <a href="https://twitter.com/LucidMotors/status/1893699834382590078?ref_src=twsrc%5Etfw">February 23, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<figcaption class="wp-element-caption">Lucid also <a href="https://www.benzinga.com/25/01/42842059/lucids-q4-deliveries-soar-to-new-highs-gravity-suv-sets-optimism-for-coming-months">unveiled its Gravity SUV</a> at the event in Riyadh.</figcaption></figure>
Why It Matters: Saudi Arabia's Public Investment Fund (PIF)&nbsp;is a majority stakeholder in Lucid. It has invested about $8 billion in Lucid since 2018. In April 2022, Saudi also agreed to purchase up to 100,000 vehicles from Lucid in a ten-year period. 
The company also has a plant in Jeddah, Saudi Arabia, aimed at assembling the Lucid Air vehicles.
The sedan starts at about 350,000 Saudi riyals for the base version and at over a million Saudi riyals for the <a href="https://www.benzinga.com/news/24/06/39135581/youtuber-mkbhd-praises-lucid-air-sapphire-if-it-couldnt-be-a-tesla-it-would-have-to-be-this">Sapphire variant</a>. 
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43905539/elon-musk-led-spacex-to-undertake-starships-8th-test-flight-on-friday" target="_blank" rel="noreferrer noopener">Elon Musk's SpaceX To Undertake Starship's 8th Test Flight On Friday</a></li>
</ul>
Image Via Lucid

Tech

LCID

Lucid Awards Limited Edition Lucid Air Sapphire With Lavender Finish To Winner Of Saudi Cup 2025

Citigroup analyst Thomas Palmer initiates coverage on Smithfield Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFD#NASDAQ">SFD</a>) with a Buy rating and announces Price Target of $27.

Initiation

Citigroup Initiates Coverage On Smithfield Foods with Buy Rating, Announces Price Target of $27

Barclays analyst Benjamin Theurer initiates coverage on Smithfield Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFD#NASDAQ">SFD</a>) with a Overweight rating and announces Price Target of $28.

Barclays Initiates Coverage On Smithfield Foods with Overweight Rating, Announces Price Target of $28

Barclays analyst Benjamin Budish initiates coverage on Blue Owl Cap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OWL#NYSE">OWL</a>) with a Overweight rating and announces Price Target of $29.

Barclays Initiates Coverage On Blue Owl Cap with Overweight Rating, Announces Price Target of $29

Barclays analyst Adrienne Yih upgrades Bath &amp; Body Works (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBWI#NYSE">BBWI</a>) from Underweight to Equal-Weight and raises the price target from $34 to $43.

BBWI

Barclays Upgrades Bath & Body Works to Equal-Weight, Raises Price Target to $43

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.rgare.com%2Fhome&amp;esheet=54212479&amp;newsitemid=20250224564600&amp;lan=en-US&amp;anchor=Reinsurance+Group+of+America%2C+Incorporated&amp;index=1&amp;md5=d64dfc6406b7cfaa605979095e98501c">Reinsurance Group of America, Incorporated</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>), a leading global life and health reinsurer, today announced it has entered into an agreement with Equitable Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQH#NYSE">EQH</a>, "Equitable"))) to reinsure a diversified block of life insurance products and expand their strategic partnership.
<ul>
<li>RGA to reinsure $32 billion of a diversified mix of life insurance products</li>
<li>RGA expects to deploy $1.5 billion of capital at closing into this reinsurance transaction</li>
<li>Priced with attractive returns within RGA's target range</li>
<li>Expected to meaningfully contribute to adjusted operating EPS</li>
<li>Broadens RGA's relationship with Equitable across underwriting, product development, distribution, and investment management</li>
</ul>

RGA Strikes $32B Reinsurance Deal With Equitable, Expects $1.5B Deployment in Equitable Deal, Sees Boost to Operating EPS

JP Morgan analyst Chris Schott upgrades Amneal Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMRX#NASDAQ">AMRX</a>) from Neutral to Overweight and raises the price target from $9 to $12.

AMRX

JP Morgan Upgrades Amneal Pharmaceuticals to Overweight, Raises Price Target to $12

Jefferies analyst Kaumil Gajrawala upgrades Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) from Hold to Buy and lowers the price target from $155 to $150.

FRPT

Jefferies Upgrades Freshpet to Buy, Lowers Price Target to $150

Cryptocurrency analyst James Van Straten shared his optimistic perspective on Bitcoin&#8217;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) ongoing market consolidation on Saturday, describing it as &#8220;bullish.&#8221;
What Happened: In an X post, Van Straten noted that, unlike the choppy period of 2024, Bitcoin&#8217;s price has consistently stayed above the Short-Term Holder Realized Price in the current cycle.
As the name suggests, the Short-Term Holder Realized Price is the average price at which short-term investors have purchased their Bitcoin. Historically, when Bitcoin&#8217;s price is above this level, it indicates a bullish market, as &#8220;weak hands,&#8221; known to have a low-risk tolerance, are in profit.
&#8220;Not all consolidations are the same. I've been beating the drum on how bullish this consolidation has been,&#8221; the analyst stated. &#8220;Investors are waiting and not chasing the price but I think impatience may prevail.&#8221;
The analyst went on to say that another dip would be &#8220;healthy&#8221; for the market.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Exactly! Not all consolidations are the same. I've been beating the drum on how bullish this consolidation has been. I've had one limit order filled since November. Investors are waiting and not chasing the price but I think impatience may prevail. Unlike 2024 chop period… <a href="https://t.co/mqfqrEMHcM">https://t.co/mqfqrEMHcM</a> <a href="https://t.co/Yf2YHAqUdJ">pic.twitter.com/Yf2YHAqUdJ</a>
&mdash; James Van Straten (@btcjvs) <a href="https://twitter.com/btcjvs/status/1893184115064627530?ref_src=twsrc%5Etfw">February 22, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Van Straten&#8217;s comments come amidst a challenging time for the crypto market, particularly for leading coins like&nbsp;Bitcoin&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTC#NYSE">BTC</a>), which has been struggling to reclaim its $100,000 mark for the past three weeks.
See Also:<a href="https://www.benzinga.com/24/12/42735744/pharma-bro-martin-shkreli-predicts-doom-for-michael-saylors-microstrategy-as-stock-dips-below-300-in-after-hours-trading"> </a><a href="https://www.benzinga.com/general/entertainment/25/02/43905274/kanye-west-deletes-x-posts-on-potential-meme-coin-unfollows-changpeng-zhao-whats-he-upto">Kanye West Deletes X Posts On Potential Meme Coin, Unfollows Changpeng Zhao — What&#8217;s He Upto?</a>
Why It Matters: Van Straten&#8217;s comments come amid a challenging time for the cryptocurrency market, particularly for leading coins like Bitcoin, which has been <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43904736/bitcoin-dogecoin-struggle-ethereum-gains-amid-grim-crypto-sentiment-after-bybits-billion-dollar-hack-analyst-says-still-time-left-in-the-cycle">struggling to reclaim its $100,000 mark</a> for the past three weeks.
The rangebound action has impacted speculative interest for the leading coin, with Open Interest in Bitcoin futures falling 10% since the beginning of the month, <a href="https://www.coinglass.com/LiquidationData">according </a>to Coinglass. 
More than 50% of Bitcoin&#8217;s derivatives traders were positioned short as of this writing, suggesting a likelihood of another correction. 
The market has been grappling with the aftermath of a massive $1.4 billion hack on cryptocurrency exchange Bybit, which has significantly impacted leading coins.
Price Action: At the time of writing, Bitcoin was exchanging hands at $95,721.70, down 0.53% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/personal-finance/financial-advisors/25/02/43903229/advisors-remain-divided-on-crypto-but-sec-approvals-demand-are-shifting-views">Advisors Remain Divided On Crypto, But SEC Approvals, Demand Are Shifting Views</a></li>
</ul>
Image via Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

$BTC

Bitcoin Poised For Growth? Analyst Says 'One More Flush' Could Set Stage For Surge

Jefferies analyst Randal Konik upgrades Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) from Hold to Buy and raises the price target from $75 to $115.

Jefferies Upgrades Nike to Buy, Raises Price Target to $115

Jefferies analyst Edison Lee downgrades GDS Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDS#NASDAQ">GDS</a>) from Buy to Hold and raises the price target from $27.06 to $45.

Jefferies Downgrades GDS Holdings to Hold, Raises Price Target to $45

Just Eat Takeaway.com N.V. (AMS: TKWY), hereinafter the "Company" or "Just Eat Takeaway.com", one of the world's leading on-demand delivery companies, and Prosus, the global technology company, are pleased to announce they have reached conditional agreement on an envisaged recommended public offer by Prosus for all issued and outstanding shares in the capital of Just Eat Takeaway.com (the "Shares", and each a "Share") of EUR 20.30 (cum dividend) in cash per Share (the "Consideration"). The Offer values a 100% of the Shares at approximately EUR 4.1 billion.

JTKWY

Earlier It Was Announced Prosus To Acquire Just Eat Takeaway.com For €4.1B In Cash

Commodities

Press Releases

Cypress Creek Renewables Selects Maxeon Solar Solutions for Major Utility Scale Projects

Stock Split

Maxeon Receives Nasdaq Notification and is Proceeding with Approved Reverse Stock Split

Pomerantz Law Firm Announces the Filing of a Class Action Against Maxeon Solar Technologies, Ltd. - MAXN

Maxeon Announces CEO Leadership Transition

Maxeon Provides Update on CBP Detention of its Solar Panels

Maxeon Announces Restructuring of Business Portfolio

Maxeon Solar Technologies Announces Third Quarter 2024 Financial Results

Maxeon and Tongwei Solar Announce Settlement Agreement Resolving Patent Infringement Lawsuit

Ascent Solar Technologies, Inc - Common Stock

Ascent Solar Technologies

Datavault AI

GCT Semiconductor Holding, Inc. Common Stock

GCT Semiconductor Hldgs

GSI Technology

Intchains Group Limited - American Depositary Shares

Intchains Gr

Kopin

SEALSQ

SemiLEDs

Mobix Labs

Everspin Technologies, Inc. - Common Stock

Everspin Technologies

Magnachip Semiconductor Corporation Common Stock

MagnaChip Semiconductor

Nano Labs

Peraso

Pixelworks

QuickLogic

Semilux International Ltd. - Ordinary Shares

Semilux International

SmartKem

Sequans Communications S.A. American Depositary Shares (each representing ten (10) Ordinary Shares)

Comments

Maxeon Solar Technologies

Maxeon Solar Technologies (MAXN) 옵션

Maxeon Solar Technologies (NASDAQ:MAXN) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌